DK3484469T3 - COMPOSITIONS AND METHODS FOR POTENTIATION OF ANTIMICROBIES - Google Patents

COMPOSITIONS AND METHODS FOR POTENTIATION OF ANTIMICROBIES Download PDF

Info

Publication number
DK3484469T3
DK3484469T3 DK17827133.4T DK17827133T DK3484469T3 DK 3484469 T3 DK3484469 T3 DK 3484469T3 DK 17827133 T DK17827133 T DK 17827133T DK 3484469 T3 DK3484469 T3 DK 3484469T3
Authority
DK
Denmark
Prior art keywords
antimicrobies
potentiation
compositions
methods
Prior art date
Application number
DK17827133.4T
Other languages
Danish (da)
Inventor
Ephraim Brener
Elran Haber
Adi Zuloff-Shani
Ascher Shmulewitz
Original Assignee
Scisparc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scisparc Ltd filed Critical Scisparc Ltd
Application granted granted Critical
Publication of DK3484469T3 publication Critical patent/DK3484469T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK17827133.4T 2016-07-14 2017-07-13 COMPOSITIONS AND METHODS FOR POTENTIATION OF ANTIMICROBIES DK3484469T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662362082P 2016-07-14 2016-07-14
PCT/IL2017/050800 WO2018011813A1 (en) 2016-07-14 2017-07-13 Compositions and methods of potentiating antimicrobials

Publications (1)

Publication Number Publication Date
DK3484469T3 true DK3484469T3 (en) 2024-06-24

Family

ID=60952228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17827133.4T DK3484469T3 (en) 2016-07-14 2017-07-13 COMPOSITIONS AND METHODS FOR POTENTIATION OF ANTIMICROBIES

Country Status (7)

Country Link
US (3) US20190183914A1 (en)
EP (1) EP3484469B1 (en)
CN (1) CN109562094A (en)
CA (1) CA3068806A1 (en)
DK (1) DK3484469T3 (en)
MA (1) MA45688A (en)
WO (1) WO2018011813A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017053574A1 (en) 2015-09-22 2017-03-30 Vitality Biopharma, Inc. Cannabinoid glycoside prodrugs and methods of synthesis
US11207291B2 (en) 2017-05-09 2021-12-28 Graphium Biosciences, Inc. Antimicrobial compositions comprising cannabinoids and methods of using the same
US20200286597A1 (en) * 2017-10-04 2020-09-10 Cannibite Bvba System for Detecting an Intraoral Disease and Determining a Personalized Treatment Scheme and Method of Doing Same
WO2020000024A1 (en) * 2018-06-28 2020-01-02 Botanix Pharmaceuticals Ltd Antibacterial treatment using cannabinoid combinations
MX2021002719A (en) * 2018-09-05 2021-09-23 Nemus Bioscience Inc Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains.
EP3873449A1 (en) * 2018-10-30 2021-09-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions comprising cannabinoids for use in the treatment of biofilm and conditions associated with microbial, fungal, bacterial infections
GB2581987B (en) * 2019-03-06 2021-11-17 Gw Res Ltd Use of cannabidiol in combination with antibiotics
WO2020194237A1 (en) * 2019-03-28 2020-10-01 Scicann Therapeutics Inc. Cannabinoid compositions and use thereof
CN109758441A (en) * 2019-03-29 2019-05-17 广东工业大学 Application and drug of the N- fatty acyl ethanolamine class compound in the drug that preparation inhibits bacterial community induction system
JP2022532116A (en) 2019-05-06 2022-07-13 ザ ユニバーシティ オブ ブリティッシュ コロンビア Antibiotic cannabinoid-terpene preparation
BR112021025364A2 (en) * 2019-06-18 2022-02-01 Botanix Pharmaceuticals Ltd Antibacterial dosing regimen with the use of cannabinoids
CN110973159B (en) * 2019-10-30 2021-04-06 广州市浪奇实业股份有限公司 Antibacterial composition containing cannabidiol and application thereof
IL293414A (en) * 2019-11-29 2022-07-01 Botanix Pharmaceuticals Ltd Antibacterial treatment using a cannabinoid and an active agent
CN112195558A (en) * 2020-09-24 2021-01-08 上海丰格无纺布有限公司 Antimicrobial non-woven fabric and preparation method thereof
WO2023130142A2 (en) * 2022-01-03 2023-07-06 Bryant Cynthia W Compositions and methods using cannabinoid compounds for treating urinary tract disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506224A (en) 1991-12-31 1996-04-09 Lifegroup S.P.A. N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes
JP4817495B2 (en) 1998-05-29 2011-11-16 ニューロサイエンシーズ・リサーチ・ファウンデーション・インコーポレーテッド Pain control with exogenous cannabinoids
US20050054730A1 (en) 2001-03-27 2005-03-10 The Regents Of The University Of California Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
WO2009158499A2 (en) * 2008-06-25 2009-12-30 University Of North Texas Health Science Center At Fort Worth Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
CN103361820A (en) * 2012-03-30 2013-10-23 太仓棨淂服装有限公司 Antibacterial denim fabric
US9095563B2 (en) * 2013-09-26 2015-08-04 Ronald D. Sekura Topical treatments incorporating Cannabis sp. derived botanical drug product

Also Published As

Publication number Publication date
US20230045747A1 (en) 2023-02-09
CA3068806A1 (en) 2018-01-18
EP3484469B1 (en) 2024-05-22
EP3484469A4 (en) 2020-07-22
US20190183914A1 (en) 2019-06-20
US20210093652A1 (en) 2021-04-01
CN109562094A (en) 2019-04-02
EP3484469A1 (en) 2019-05-22
MA45688A (en) 2019-05-22
US11491172B2 (en) 2022-11-08
WO2018011813A1 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
DK3484469T3 (en) COMPOSITIONS AND METHODS FOR POTENTIATION OF ANTIMICROBIES
DK3356529T3 (en) COMPOSITIONS AND METHODS FOR INHIBITING LENA EXPRESSION OF LPA
DK3212778T3 (en) Methods and compositions for stabilizing trans-splicing of intein-modified proteases
DK3368541T3 (en) COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
DK3102673T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-TALASSEMI
DK3137605T3 (en) COMPOSITIONS AND METHODS FOR MODULATING ANGIOPOIETIN-LIKE-3 EXPRESSION
DK3495023T3 (en) SEMIFLUOROIATED COMPOUNDS AND COMPOSITIONS THEREOF
DK3283107T3 (en) COMPOSITIONS INCLUDING A COMBINATION OF IPILIMUMAB AND NIVOLUMAB
DK3144001T3 (en) Compositions of selenoorganic compounds and methods of their use
DK3234133T3 (en) CRISPR-BASED COMPOSITIONS AND METHODS OF USE
DK3212226T3 (en) COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS
DK3393655T3 (en) FENFLURAMIN COMPOSITIONS AND METHODS FOR THE PREPARATION OF THE SAME
DK3152312T3 (en) METHODS AND COMPOSITIONS FOR MODIFICATION OF A TARGET LOCUS
DK3316909T3 (en) ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
DK3556869T3 (en) COMPOSITIONS AND METHODS FOR SEQUENCE OF POLYNUCLEOTIDES
DK3319948T3 (en) Acesulfame-potassium compositions and methods for their preparation
DK3317400T3 (en) PROCEDURE FOR CRYO-PRESERVATION OF TUMOR-INFILRATING LYMPOCYTS
DK3277270T3 (en) COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF ANEMIA
DK3519572T3 (en) COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION
DK3102555T3 (en) COMPOSITIONS OF THE COMPOUNDS AND USES THEREOF
DK3322695T3 (en) Acesulfame-potassium compositions and methods for their preparation
DK3209696T3 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GLIOBLASTOM
DK2924093T3 (en) Multicarboxylate compositions and processes for their preparation
DK3394259T3 (en) COMPOSITIONS AND METHODS FOR REDUCING TAU EXPRESSION
DK3261726T3 (en) COMPOSITION FOR TREATMENT OF ACNE